
CDCã¯æäººããã³åäŸã®COVIDã¯ã¯ãã³ã«å¯ŸããŠãã¡ã€ã¶ãŒã«12å4åäžãã«ãæ¯çµŠããããšãå³ããéé£
å èšäºã¯ãã¡ããã/Click here to read the original article.
CDCã¯å æãæäººåãCOVIDã¯ã¯ãã³ã§ãã¡ã€ã¶ãŒã«5åãã«ãåäŸçšã¯ã¯ãã³ã§7å3,500äžãã«ã®æ°èŠå¥çŽãçµã³ãŸãããããããã®æ³šå°ã¯æ·±å»ãªå¥åº·ãªã¹ã¯ã䌎ã£ãŠããŸãã
ã¯ã·ã³ãã³D.C.(LifeSiteNews)â ç±³åœçŸç 察çã»ã³ã¿ãŒ(CDC)ã¯ã補è¬å€§æãã¡ã€ã¶ãŒã«å¯Ÿãã2026äŒèšå¹ŽåºŠãã2027幎床ã«ãããŠæäººããã³åã©ãåãã®COVID-19ã¯ã¯ãã³ã®æ°èŠå¥çŽãšããŠ12å4åäžãã«ãæäžããŸãããããã«ããããã©ã³ãæ¿æš©ããããããã¢ã¡ãªã«ãå¥åº·ã«åã³ãã(MAHA)ãæ¿çãžã®ã³ãããã¡ã³ãã«åãçµãã§ãããšããçåãåçããŠããŸãã
å ææäžãããå¥çŽã§ã¯ã æäººåãCOVID-19ã¯ã¯ãã³ã«5å527äž2åãã«ãå°å çšCOVID-19ã¯ã¯ãã³ã«7å3,572äž0,598ãã«ãä»äžãããŠããŸãããã®åŸããã³ã»ãžã§ã³ãœã³äžé¢è°å¡(å ±åå ã»ãŠã£ã¹ã³ã³ã·ã³å·)ã¯ãä¿å¥çŠç¥ç(HHS)ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢é·å®ãCDC代çå±é·ãžã§ã€ã»ãã¿ãã£ãªã€ãç±³åœé£åå»è¬åå±(FDA)代çã³ããã·ã§ããŒãã«ã€ã«ã»ãã£ã¢ãã³ã¿ã¹é·å®ã«åçãæ±ããæžç°¡ãéããŸããã
ãžã§ã³ãœã³æ°ã¯ãå°å§å¡äŒããããŸã§ã«æããã«ããCOVID-19泚å°ã®å®å šæ§åé¡ã¯ãHHSãCDCãmRNAã¯ã¯ãã³æ³šå°ã«å¯ŸããŠæ·±å»ãªæžå¿µãæ±ãã¹ãã ã£ãããšæžããŠããŸãããããããCDCããã¡ã€ã¶ãŒã«çŽ12å4åäžãã«ã®æ°èŠå¥çŽãæäžãããšå ±åããã®ã¯ãåã©ãã®æ»äº¡ãå«ãæ·±å»ãªæå®³äºè±¡ã«é¢é£ããã¯ã¯ãã³ã®å¯Ÿè±¡ã§ãããCDCãã¯ã¯ãã³å®å šè²¬ä»»ãçå£ã«åãæ¢ããŠããªãããšã瀺åããŠããŸããã
å é±ãThe Hillã®ããã«ãã»ã¹ããŒã¿ãŒã¯ãã¯ã¯ãã³ã«å¯Ÿããç¶ç¶çãªææ§ããããMAHAææš©è ã®éã§å ±åå ã代åãæãå¯èœæ§ããããšèŠåããŸãããã2026å¹Žæ¥æç¹ã§ãCOVID-19ã¯ã¯ãã³ã®æ¥çš®çã¯ããªãäœãã§ããåã©ãã®9%ãæäººã®17%ãææããŠããŸãããã芪ã®ãã¡ãåã©ãã«æ¥çš®ãåžæããŠããã®ã¯ããã3%ã§ãããšåœŒã¯æžããŠããŸãã
ãæè¿ã®KFFã®äžè«èª¿æ»ã§ã¯ãMAHAæ¯æè ã®56%ã11æã®åè£è ã«å»çè²»ã倧ããªåœ±é¿ãäžãããšçããŠããããšã¹ããŒã¿ãŒã¯ä»ãå ããããã¯ã¯ãã³æ¿çã«ã€ããŠãçŽ4å²ãåãããšãèšã£ãŠããŸãã圌ãã¯æ±ºããŠéèŠèŠã§ããªãææš©è ã§ã¯ãããŸãããç«¶äºã®æ¿ããéžæåºã§ã¯ã圌ãã¯åå©ã®å·®ã象城ããå¯èœæ§ãããããšè¿°ã¹ãæš©åãã©ã³ã¹ã®å€åã ãã§ãªãããå ±åå ã®æ¢æå¢åãããã°ãã¡ãŒãã«å±æããæ¹é©æŽŸãç¡ååããããšããç©èªã確èªãããMAHAé£åã¯éžææŠäžã¯æçšã ã£ããæ¿æš©å ã§ã¯äœ¿ãæšãŠã ããšãã䞻匵ãè£ä»ãããããªã¹ã¯ãããã
å€ãã®èšŒæ ããCOVIDã¯ã¯ãã³ãæåŠããå®æçæ ¹æ ãšå»ççæ ¹æ ã®äž¡æ¹ãè£ä»ããŠããŸãã
é£éŠã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã (VAERS)ã¯ã6æ26æ¥æç¹ã§39,182äººã®æ»äº¡ã222,828人ã®å ¥é¢ã22,549ä»¶ã®å¿èçºäœã29,245ä»¶ã®å¿ççããã³å¿èçãªã©ããã®ä»ã®çŸæ£ãå ±åããŠããŸããVAERSã®æåºã ãã§ã¯èšŒæãããçäŸã§ã¯ãããŸãããã2022幎ã«CDCã®ç ç©¶è ãã¡ã¯ãmRNAããŒã¹ã®COVID-19ã¯ã¯ãã³æ¥çš®åŸã«VAERSãžã®å¿ççã®å ±åãé«ã確çã§ç¢ºèªãããããéå€§å ±åãããéå°å ±åã®æ¹ãå¯èœæ§ãé«ãããšçµè«ã¥ããŸããã
æšå¹ŽãåŠè¡èªãVaccineãã«æ²èŒããã8ãåœ9,900äžäººã察象ãšããåæã§ã¯ããmRNAãåºç€ãšããCOVIDã¯ã¯ãã³ã®1åç®ã2åç®ã3åç®ã®æ¥çš®åŸã«å¿ççã®ãªã¹ã¯ãå€§å¹ ã«å¢å ãããå¿èçãã®ã©ã³ã»ãã¬ãŒçå矀ãè³éèæŽè¡æ çãã®ãªã¹ã¯å¢å ãããããªã調æ»ãå¿ èŠãªãã®ä»ã®ãæœåšçãªå®å šæ§ã·ã°ãã«ãã®å åã芳å¯ãããŸããã2024幎4æãCDCã¯è£å€æã®åœä»€ã«ããããããŸã§éå ¬éã ã£ã78äžä»¶ã®æ·±å»ãªå¯åå¿å ±åãå ¬éããããåŸãŸããã§ããããŸããæ¥æ¬ã®ç ç©¶ã§ã¯mRNAããŒã¹ã®COVID-19ã¯ã¯ãã³3åæ¥çš®åŸã®ããæ»äº¡çããçµ±èšçã«ææã«å¢å ãããå æé¢ä¿ã«ã€ããŠããã€ãã®ä»®èª¬ã瀺ãããŸããã æè¿ã§ã¯ãåœéææçãžã£ãŒãã«ãã€ã³ã¿ãŒãã·ã§ãã«ã»ãžã£ãŒãã«ã»ãªãã»ã¡ãã£ã«ã«ã»ãµã€ãšã³ã¹ã«æ²èŒãããç ç©¶ãããã®ã¯ã¯ãã³ãåŒåžåšçŸæ£ã ãã§ãªãè èé害ã®ãªã¹ã¯ã䌎ãå¯èœæ§ã瀺åããŸããã
å»çãªã¹ã¯ã«å ããå€ãã®å®æçã»çåœå°éã®ã¢ã¡ãªã«äººã¯ãéçºæ¹æ³ã®å«ççåé¡ããé埳ççç±ããã¯ã¯ãã³ã«å察ããŠããŸãã
ããã©ã€ãå£äœã·ã£ãŒãããã»ããŒãžãšç ç©¶æã®è©³çŽ°ãªæŠèŠã«ãããš ããã¡ã€ã¶ãŒãã¢ãã«ãããžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ã¯ããããCOVIDã¯ã¯ãã³ã®æ€æ»æ®µéã§äžçµ¶ãããèµ€ã¡ããç±æ¥ã®çްèã䜿çšãããžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ã¯èšèšã»éçºã»çç£æ®µéã§ããããã®çްèã䜿çšããŸãããã¢ã¡ãªã«ç§åŠæ¯èåäŒã®åŠè¡èªããµã€ãšã³ã¹ããã巊掟系ã®ããã¡ã¯ããã§ãã¯ãã¡ãã£ã¢ãã¹ããŒãã¹ããããã®æ³šå°ãäžçµ¶ãšé¢é£ããŠããããšãèªããŠãããå€ãã®äººããããšé¢ããããšã«é埳çãªå«æªæãæ±ããŠããã
æ°äž»å ã¯ã»ãŒãã¹ãŠã®ã¯ã¯ãã³æ¥çš®ã«è³æããŠããŸãããå ±åå å ã®åå¿ã¯å¯Ÿç«ããŠããŸããããã¯ããã©ã³ãæ¿æš©ã®æåã®ãã¯ãŒãã¹ããŒãäœæŠãã€ãã·ã¢ã ããããããŸã§ã®ã©ã®ã¯ã¯ãã³ãããã¯ããã«çãæéã§COVIDã¯ã¯ãã³ãæºåã»å ¬éããããšããããŠå€§çµ±é ããããåŠå®ããªãã£ãããšã«ãããŸãã
ãããŸã§ã®ãšããããã©ã³ãæ¿æš©ã®ç¬¬2ææ¿æš©ã¯ã¯ã¯ãã³ã«é¢ããããã€ãã®å§åãæ€åããŸãããããŸã åžå Žããæ€å»ã¯ããŠããŸãããCOVIDäœå¶ã®å£°é«ãªæ¹å€è ãæ°åéããç±³åœã§æãèåãªåã¯ã¯ãã³æŽ»åå®¶ã±ããã£æ°ã®æå°äžã«HHSã眮ããã«ããããããã§ããæ¿æš©ã¯çŸåšã®ã¯ã¯ãã³ãä»»æã«ãã€ã€ãåŸç¶ã¯ã¯ãã³ã®éçºãæ¯æãããCOVIDèªäœã®æšå¥šã¯ãé«ãªã¹ã¯ãã°ã«ãŒãã«éå®ãããšããæ±ºå®ãã»ãŒæ±ºå®ããŠããŸãã
2025幎7æã®ã€ã³ã¿ãã¥ãŒã§ãèŸä»»ããFDAé·å®ã®ããŒãã£ã»ãã«ãªãŒå士 ã¯ãã¯ã¯ãã³ã®æ±ãã«äžæºãæã€äººã ã«å¿èãæ±ããããæ±ºå®çãªããŒã¿ãåŸãããã«å æ¬çãªè©Šéšã«ãã£ãšæéãå¿ èŠã ãšäž»åŒµããŸãããFDAã¯ã¯ã¯ãã³ã«ããåã©ãã®æ»äº¡ãèªãå§ããŠãããšå ±ããããŠããŸãããåæã«ãã©ã³ãæ¿æš©ã®åžæ³çã¯ãã¡ã€ã¶ãŒã«å¯Ÿããå éšåçºè ã®èšŽèšã®åŸ©æŽ»ã«æ³å»·ã§å察ããŠããŸãã
2æã«ã¯ã補è¬å€§æã¢ãã«ãã®æ°åmRNAããŒã¹ã®ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®è©Šéšç³è«ã審æ»ããããšã確èªãã倧統é ã®ä»å ¥ããã£ããšå ±ãããã以åã®åŽäžãèŠããŸããã